Jay Matushak - 09 May 2025 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role: Chief Financial Officer
Signature: /s/ Eric Halverson for Jay Matushak, Attorney-in-Fact
Issuer symbol: NEUE
Transactions as of: 09 May 2025
Net transactions value: $0
Form type: 4
Filing time: 13 May 2025, 18:06:05 UTC
Previous filing: 17 Mar 2025
Next filing: 14 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Matushak Jay	Chief Financial Officer	C/O NEUEHEALTH, INC., 8000 NORMAN CENTER DRIVE, SUITE 900, MINNEAPOLIS	/s/ Eric Halverson for Jay Matushak, Attorney-in-Fact	13 May 2025	0001977975

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEUE	Common Stock	Options Exercise		+978	+2.4%		41,028	09 May 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEUE	Restricted Stock Units	Options Exercise	$0	-978	-100%	$0.000000	0	09 May 2025	Common Stock	978		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2	These restricted stock units vested over three years as follows: (a) one-third of the original grant amount vested on May 9, 2023, (b) one-third of the original grant amount vested on May 9, 2024, (c) and one-third of the original grant amount vested on May 9, 2025.